Corsi, Domenico Cristiano
 Distribuzione geografica
Continente #
NA - Nord America 170
EU - Europa 100
AS - Asia 34
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 315
Nazione #
US - Stati Uniti d'America 170
SE - Svezia 38
CN - Cina 16
IT - Italia 13
IE - Irlanda 11
DE - Germania 9
SG - Singapore 9
FR - Francia 7
CI - Costa d'Avorio 6
BE - Belgio 4
HK - Hong Kong 4
LU - Lussemburgo 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 2
GB - Regno Unito 2
JP - Giappone 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
FI - Finlandia 1
KR - Corea 1
LT - Lituania 1
NL - Olanda 1
NO - Norvegia 1
SC - Seychelles 1
TR - Turchia 1
VN - Vietnam 1
Totale 315
Città #
Chandler 57
Dublin 11
Ashburn 9
San Mateo 9
Abidjan 6
Ann Arbor 6
Bremen 6
Marseille 6
Princeton 6
Boston 5
Houston 5
Singapore 5
Brussels 4
Fairfield 4
Hangzhou 4
Montepulciano 4
New York 4
Redwood City 4
Wilmington 4
Andover 3
Jacksonville 3
Moscow 3
Cattolica 2
Dearborn 2
Formia 2
Guangzhou 2
Hong Kong 2
Nanjing 2
Seattle 2
Tianjin 2
Woodbridge 2
Acton 1
Amsterdam 1
Augusta 1
Beijing 1
Boardman 1
Brdo 1
Changsha 1
Clearwater 1
Cranford 1
Fasano 1
Geneva 1
Hanoi 1
Helsinki 1
Izmir 1
Los Angeles 1
Milan 1
Nagold 1
Norwalk 1
Redmond 1
Sandston 1
Seoul 1
Shenzhen 1
São Paulo 1
Washington 1
Wenzhou 1
Xian 1
Yardley 1
Šiauliai 1
Totale 214
Nome #
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 73
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 71
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 61
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 45
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM) 37
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial 25
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review 5
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review 4
Role of radiomics in predicting lymph node metastasis in gastric cancer: a systematic review 3
Totale 324
Categoria #
all - tutte 1.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 5 0 0 0 0 5 2 0 2 0 2 0
2020/20214 0 0 0 1 0 0 1 0 0 1 1 0
2021/202276 0 14 5 5 5 2 2 12 5 5 6 15
2022/2023143 18 23 11 24 11 19 13 6 12 3 3 0
2023/202457 4 13 1 3 3 5 4 3 0 2 3 16
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 324